Key facts
- This page summarizes Andrew Regan's Form 4 filing for CDT Equity Inc. (CDT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 27 Oct 2026, 16:33.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Other
Other
Other
Other
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
On August 31, 2026, in connection with his resignation as Chief Executive Officer and a director of CDT Equity Inc. (the "Issuer") effective as of that date, Dr. Regan became eligible to receive $300,000 in severance payments. On October 23, 2026, at the Issuer's request, $65,000 of the remaining severance payment was converted into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"), at a conversion price of $0.1301 per share, and Dr. Regan received 499,616 shares of Common Stock upon such conversion.
Footnote F2
These shares of Common Stock are owned of record by Manoira Corporation ("Manoira"). On October 22, 2026, Manoira entered into an Evaluation Agreement with the Issuer (the "Evaluation Agreement"), pursuant to which the Issuer agreed to pay Manoira a one time fee of $195,000 for the services to be provided by Manoira thereunder. On October 22, 2026, the Issuer issued to Manoira 1,347,616 shares of Common Stock in full satisfaction of the fee due to Manoira, at a price of $0.1447 per share.
Footnote F3
These shares of Common Stock are owned of record by Corvus Capital Limited ("Corvus").
Footnote F4
Corvus owns 87.0% of the outstanding equity interests of Manoira and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.